Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose

Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose

Conditions: Type 1 Diabetes
Interventions: Drug: Insulin Degludec; Drug: Insulin Glargine; Drug: Placebo
Sponsors: University of Washington
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 29, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments